Differential Regulation of Methionine Adenosyltransferase in Superantigen and Mitogen Stimulated Human T Lymphocytes*

(Received for publication, November 20, 1996, and in revised form, April 16, 1997)

H Leighton LeGros Jr. Dagger §, Arthur M. Geller and Malak Kotb Dagger §par **

From the Departments of Dagger  Surgery,  Biochemistry, and par  Microbiology and Immunology, The University of Tennessee, Memphis, Tennessee, 38163 and § The Veterans Administration Medical Center, Memphis, Tennessee 38104

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Superantigens interact with the T cell receptor for antigen (TCR) and are, therefore, more physiological stimulators of T lymphocytes than nonspecific polyclonal T cell mitogens. The effects of these two classes of T cell stimulators on methionine adenosyltransferase (MAT) and S-adenosylmethionine (AdoMet) levels were investigated. Activation of resting human peripheral blood T lymphocytes by the mitogen phytohemagglutinin (PHA) or the superantigen staphylococcal enterotoxin B (SEB) caused a 3- to 6-fold increase in MAT II specific activity. Although the proliferative response was higher in cultures stimulated with PHA compared with SEB, MAT II activity was comparable in both cultures. Both stimuli caused down-regulation of the MAT 68-kDa lambda  subunit expression and induced a comparable increase in the expression of the catalytic alpha 2/alpha 2' subunit mRNA and protein. However, in superantigen-stimulated cells, the expression of the noncatalytic beta  subunit was down-regulated and virtually disappeared by 72 h post-stimulation; whereas, no change in the expression of this subunit was noted in PHA-stimulated cells. Thus, at 72 h following stimulation, PHA-stimulated cells expressed MAT II alpha 2/alpha 2' and beta  subunits while SEB-stimulated cells expressed the alpha 2/alpha 2' subunits only; the beta  subunit was no longer expressed in superantigen-stimulated cells. Kinetic analysis of MAT II in extracts of PHA- and SEB-stimulated cells using reciprocal kinetic plots revealed that in the absence of the beta  subunit the Km of the enzyme for L-methionine (L-Met) was 3-fold higher than in the presence of the beta  subunit. Furthermore, AdoMet levels were 5-fold higher in cell extracts lacking the beta  subunit (SEB-stimulated cell extracts) compared with extracts containing MAT II alpha 2/alpha 2' and beta  subunits. We propose that the increased levels of AdoMet in superantigen-stimulated cells may be attributed to the absence of the beta  subunit, which seems to have rendered MAT II less sensitive to product feedback inhibition by (-)AdoMet. The data suggest that the beta  subunit of MAT II, which has no catalytic activity, may be a regulatory subunit that imparts a lower Km for L-Met but increases the sensitivity to feedback inhibition by AdoMet. The down-regulation of the beta  subunit, which occurred when T cells were stimulated via the TCR, may be an important mechanism to regulate AdoMet levels at different stages of T cell differentiation under physiological conditions.


INTRODUCTION

Methionine adenosyltransferase (MAT)1 (ATP:L-methionine S-adenosyltransferase, EC 2.5.1.6) is a key enzyme in cellular metabolism because it catalyzes the formation of S-adenosylmethionine (AdoMet) from L-methionine (L-Met) and ATP. In addition to being the major methyl group donor and a precursor for polyamine biosynthesis, AdoMet regulates several important intracellular enzymatic reactions including those involved in polyamine synthesis and one carbon metabolism (1-4). In mammals, there are at least two MAT isozymes, designated MAT I/III and MAT II (5-7), that have distinct tissue distribution, subunit composition, and kinetic properties (for review, see Refs. 3 and 8). MAT I/III represents a different oligomeric state of the same 48-kDa catalytic subunit designated alpha 1 (8). MAT I (200 kDa), which is a tetramer, and MAT III (100 kDa), which is a dimer of the alpha 1 subunit, differ considerably in their physical properties and in their Km for L-Met (4-7, 9-13), suggesting that differences in the oligomeric state of the alpha 1 subunit has a profound effect on the enzyme properties (for review, see Refs. 3 and 4).

The second mammalian MAT isozyme, MAT II, appears to have a wider tissue distribution than MAT I/III and has been detected in many tissues including erythrocytes (14), lymphocytes (15), brain (16), kidney (6, 17), testis (10), lens (18), and fetal liver (19, 20) and to a lesser extent in adult liver (21). Although the alpha  catalytic subunits of MAT I/III and MAT II are similar, they are products of distinct genes designated MAT1A and MAT2A that encode for the alpha 1 and alpha 2 catalytic subunits, respectively (8). The alpha 1 and alpha 2 subunits are only 84% homologous at the amino acid level, and each consists of 395 amino acids with a predicted Mr of 43,600; however, both subunits migrate anomalously on SDS-PAGE with an apparent size of 48-53 kDa (for review, see Ref. 3).

In humans, the alpha 2 subunit of MAT II appears to undergo post-translational modification to generate alpha 2' subunits (15, 22). In addition, the alpha 2/alpha 2' subunits have been shown to be associated with a catalytically inactive (21, 23) 38-kDa subunit that has been designated beta  (15). This hetero-oligomeric form of MAT II (185 kDa), which consists of both alpha 2 and beta  subunits, has been found in human lymphocytes, bovine brain, Ehrlichs ascites tumor, and calf thymus (15, 16). The exact oligomeric state of MAT II is not entirely clear, and the relative ratio of alpha 2/alpha 2' and beta  subunits in the holoenzyme is not known. However, based on the available Mr and amino acid composition data, we hypothesize that it may be in the form of alpha 2nbeta n, alpha 2/alpha 2'beta n, and/or alpha 2'nbeta n, where n is either 2 or 3. Thus, for the time being and for simplicity, we shall refer to this form as (alpha 2/alpha 2')xbeta y.

Studies of MAT II from human leukemia cells revealed that the (alpha 2/alpha 2')xbeta y form has a low Km for L-Met (3.5-20 µM) and is strongly and synergistically inhibited by all three of its end products, Pi, PPi, and AdoMet (15, 24). However, recent data showed that recombinant alpha 2/alpha 2' subunits expressed in Escherichia coli had a Km for L-Met of 80 µM (23), suggesting that the association of the alpha 2/alpha 2' subunits with the beta  subunit lowers the Km for L-Met.

Despite the availability of detailed information on the kinetic behavior of pure MAT II, the regulation of MAT II in mammalian tissues remains poorly understood, and the relative contribution of the different MAT subunits to enzyme activity and/or regulation is at present not clear. In an effort to address this problem, we have focused our studies on MAT II from human T lymphocytes. We recently reported that in addition to the alpha 2/alpha 2' and beta  subunits, normal resting human lymphocytes have another 68-kDa protein, which has MAT activity, that we have designated lambda  (21). The lambda  protein is also found in human liver and is the only form of MAT in certain types of myelogenous leukemia cells (21). When T lymphocytes are stimulated to divide, lambda  disappears while the alpha 2/alpha 2' subunits, which have higher MAT activity than lambda , concomitantly increase (21). Activation of T cells and the switch in the expression of MAT subunits is accompanied by a significant increase in enzyme activity as well as AdoMet levels and turnover (21, 25, 26). Inasmuch as AdoMet is a strong inhibitor of MAT, the paradoxical simultaneous increase in both AdoMet turnover and AdoMet levels suggests the existence of a cellular regulatory mechanism that allows MAT to remain active in the presence of high concentrations of its products (24). To further investigate this phenomenon, it was necessary to conduct our investigation under more physiological conditions.

Under physiological conditions, T cells are activated via the T cell receptor (TCR) for antigen. The engagement of TCR by antigen transmits important biochemical signals that, together with other essential costimulatory signals derived from antigen-presenting cells (APC), program T cells to divide and differentiate (for review, see Refs. 27-29). Nonspecific polyclonal mitogens (e.g. PHA) are nonphysiological stimulators of T cells, and studies have documented differences in the biochemical signals triggered as a result of TCR occupancy versus those elicited by the interaction of polyclonal mitogens with their respective receptors on T cells (30-33). Differences in the signals used, and hence the biochemical pathways triggered, can have major effects on T cell differentiation and function.

Superantigens are a newly characterized class of molecules that activate T cells by engaging their TCR (for review, see Refs. 34 and 35). Whereas the binding of nominal antigen to the TCR is highly specific and is dependent on the five variable elements of the TCR, namely Vbeta , Dbeta , Jbeta , Valpha , and Jalpha , the binding of superantigen to the TCR is somewhat less specific because superantigens interact with T cells based on their Vbeta type without regard for the fine specificity of the TCR (for review, see Refs. 34 and 35). Each superantigen has a characteristic affinity to a set of Vbeta elements and can stimulate virtually all T cells that express them (34). This number can reach 5-40% of resting T cells, compared with <= 0.001% of cells that can be stimulated by a typical antigen. Consequently, biochemical signals triggered by superantigen in resting T cells can be readily measured. The ability of superantigens to stimulate large numbers of T cells, together with the fact that stimulation occurs via the TCR, provides an ideal system for studying biochemical events triggered in activated T cells under physiological conditions that mimic antigenic stimulation (32).

In this study, the effects of a nonspecific mitogen and superantigen activation of T cells on MAT activity and the temporal expression of its subunits were compared. We show that, although both mitogen and superantigen induced an increase in MAT activity, they had different effects on MAT II subunit expression and consequently on the kinetic properties of the enzyme. Specifically, we show that the expression of the beta  subunit is down-regulated in superantigen-stimulated T cells and that this phenomenon is associated with a marked increase in intracellular AdoMet concentration and with a form of MAT II that has a reduced affinity for L-Met but is less susceptible to feedback inhibition by AdoMet. These results suggest that the role of the beta  subunit may be regulatory, and the findings underscore the importance of conducting studies of MAT in T cells under physiological conditions.


EXPERIMENTAL PROCEDURES

Materials

Aprotinin, antipain, chymotrypsin, leupeptin, pepstatin A, phenylmethanesulfonyl fluoride, benzamidine, o-phenanthroline, bicinchoninic acid, SEB, and PHA were from Sigma. All tissue culture reagents were purchased from Cellgro. The ECL chemiluminescence detection system was from Amersham Life Science, Inc. Nitrocellulose membranes were from Fisher Scientific, and the RX medical x-ray film was from Fuji.

Cell Culture

All cells were cultured in RPMI medium supplemented with 10% heat-inactivated fetal bovine serum, 50 µg/ml streptomycin, and 50 units/ml penicillin (referred to as RPMI complete). PBMC were isolated from peripheral blood by Ficoll-Hypaque density centrifugation, washed twice, and then resuspended in RPMI complete. The cells were adjusted to 1-2 × 106 cells/ml and stimulated with either PHA (Boehringer Mannheim) or the staphylococcal superantigen SEB (Sigma). At specific times after the initiation of culture, the cells were harvested and used for determination of MAT II activity and kinetic properties, MAT alpha 2 subunit mRNA expression, MAT lambda , alpha 2/alpha 2', and beta  subunits protein expression, and AdoMet levels as detailed below. Parallel cultures were set up in 96-well plates and harvested at 48 or 72 h for assessment of the proliferative response.

Assessment of Cell Proliferation and Measurement of DNA Content

PBMC were cultured at 105 cells/200 µl RPMI complete in 96-well round bottom plates. The cells were stimulated with either PHA or SEB and incubated at 37 °C in 5% CO2 and 95% humidity. PHA- and SEB-induced blastogenic responses were assessed by measuring [3H]thymidine uptake at 24, 48, and 72 h post-stimulation. Five h prior to harvesting, cells were pulsed with 1 µCi/well of [3H]thymidine (specific activity = 6.7 Ci/mmol, DuPont Co., Wilmington, DE), harvested onto glass fiber filters using an automated cell harvester, and counted in a Packard liquid scintillation counter. The precipitable radioactivity are presented as mean cpm [3H]thymidine uptake of triplicate cultures ± S.E.

DNA content was measured by the method of Burton (37) in acid-insoluble precipitate of cells extracted with 2 N perchloric acid (PCA).

Preparation of Cell Extracts

MAT activity was assayed in extracts prepared from cell pellets by three cycles of freeze-thawing. The enzyme extraction buffer consisted of 50 mM Tris, pH 7.4, 50 mM NaCl, 5 mM MgCl2, 4 mM DTT, and a mixture of the following proteolytic inhibitors: 50 µg/ml aprotinin, 25 µg/ml leupeptin, 10 µg/ml phenylmethanesulfonyl fluoride (15, 21). The protein concentration in the cellular extracts was determined by the Bradford method (36) with the dye-binding kit from Bio-Rad and/or by the bicinchoninic acid method (37) from Sigma.

MAT Assay

MAT activity was assayed as described previously (15, 21). The standard assay contained 20 µM L-Met, 5 mM ATP in 50 mM TES buffer, pH 7.4, 50 mM KCl, 15 mM MgCl2, 0.3 mM EDTA, and 4 mM DTT. The Met concentration was varied as indicated in the kinetic analysis. One unit of MAT activity is defined as the amount of enzyme that catalyzes the formation of 1 nmol of AdoMet in 1 h.

Analysis of kinetic data was performed both manually by the Lineweaver-Burk and the S/v versus S plots and confirmed by PSI-Plot software (Poly Software International) and the Marquardt algorithm. The kinetic data were fit to nonlinear least squares analysis to the Adair-Scatchard equation (45) for one and two catalytic sites.

SDS-PAGE and Western blotting

The same cell extracts assayed for MAT activity as described above were diluted in loading buffer (60 mM Tris-Cl, pH 6.8, 2% SDS, 5% 2-mercaptoethanol, and 5% glycerol), heated in a boiling water bath for 4 min, and analyzed by SDS-PAGE (10% total acrylamide, 2.7% bisacrylamide) as described previously (21). After electroblotting the proteins onto the nitrocellulose for 1 h at 25 to 30 V/cm, the blots were blocked overnight with 6% nonfat dry milk in TBS (50 mM Tris, pH 7.5, and 150 mM NaCl), washed in TBS, and incubated with primary polyclonal anti-holoenzyme antisera, or polyclonal antisera generated against synthetic peptides of the alpha  or the beta  subunits (22). The blots were developed with secondary anti-rabbit antibodies conjugated to horseradish peroxidase and the luminol-chemiluminescence reagents (Amersham ECL) (21). The processed blots were exposed to x-ray film, and the autoradiograms were analyzed. For some experiments, the autoradiograms were scanned using a Howtek Scanmaster-3 scanner (Protein Data Base, Inc., Huntington Station, NY), and the intensity of the desired band was integrated and expressed in arbitrary units.

Semi-quantitation of MAT II alpha 2 Subunit mRNA Expression by Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)

Normal, resting PBMC (2 × 106) were stimulated with PHA or SEB for specific time intervals. At the desired times, the cells were harvested and counted, and total RNA was extracted using RNAzol-B (Tel-Test Inc., Friendswood, TX) as described previously (38). The RNA was treated with RNase-free DNase to remove contaminating DNA that could interfere with the PCR analysis. First-strand cDNA was prepared from 2 µg of RNA using superscript reverse transcriptase (Promega, Madison, WI), and random hexanucleotides (Boehringer Mannheim). The reaction contained in 20 µl: 2 µl of 10 × PCR buffer (0.2 M Tris-HCl, pH 8.4, 0.5 M KCl, 15-20 mM MgCl2, and 100 µg/ml nuclease-free bovine serum albumin); 2 µl of 10 mM dNTPs mix; 2 µg of random hexanucleotides; 2.5 mM DTT; 1 unit of RNase inhibitor; and 200 units of RT/µg of RNA. The reaction was incubated for 45 min at 37 °C and terminated by heating at 95 °C for 10 min followed by rapid chilling in ice-water for 2 min.

The cDNA was amplified in the presence of Taq polymerase (0.25 units) using primers that are specific for MAT II alpha 2 subunit (forward primer, 5'-GCC-GCT-GCT-CCT-TCG-TAA-G-3'; reverse primer, 5'-ACC-CCA-ACC-GCC-ATA-AGT-GT-3') and that amplified an 870-bp product. Amplification of a 590-bp glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA was included in each reaction as an internal control. All primers were used at 0.3 µM, and the concentration of Mg2+ was optimized for each primer set. Quantification of the amplified products was achieved by the inclusion of 32P-labeled reverse primers (106 cpm of each/reaction) that were labeled using T4 polynucleotide kinase (Promega) and [gamma -32P]ATP (Dupont) (38). After 20-25 PCR cycles consisting of 95 °C denaturation (1 min), 55 °C annealing (1 min), and 72 °C extension (1 min), the radiolabeled PCR products were separated on 2% agarose gels in TBE buffer, pH 8.0 (0.09 M Tris-base, 0.09 M boric acid, and 2 mM EDTA). The gels were dried, subjected to autoradiography, and scanned using Howtek Scanmaster-3 scanner (Protein Data Base, Inc.). For each experiment, the cDNA from each culture was titrated in pilot PCR reactions to determine the optimal amount that can be used for linear amplification. Results of the semi-quantitative PCR are expressed in arbitrary scanning units. Integrated values for the MAT II alpha 2 subunit bands are normalized to the integrated values of the GAPDH internal control to allow comparisons among samples. To rule out reagent contamination, controls include reactions with no added template, no added primers, or reactions with untranscribed RNA.

Detection and Quantitation of MAT mRNA Expression by Northern Blot Analysis

At specific times poststimulation, total RNA was extracted (108 cells yield ~300 µg of RNA), and in some experiments, mRNA was isolated using oligo(dT)-cellulose. Total RNA (20 µg) or the eluted mRNA (5 µg of mRNA) was precipitated and resuspended in MOPS buffer (40 mM MOPS, 10 mM Na-acetate, 1 mM EDTA final concentration) at pH 7.1, 3.3 µl of 37% formaldehyde, and 10 µl of formamide to a final 20 µl in diethyl pyrocarbonate-treated water. The samples were incubated for 15 min at 65 °C and then chilled on ice prior to loading. Samples were centrifuged briefly, mixed with 2 ml of loading buffer (1 mM EDTA, pH 8.0, 0.25% w/v bromphenol blue, 0.25% w/v xylene cyanol, 50% v/v glycerol), immediately loaded onto a 1.2% agarose gel in MOPS buffer with 0.01% formaldehyde, and subjected to electrophoresis at 125 V constant for 3.5 h. In one lane, total RNA was loaded to allow staining and photographing of the 28 and 18 S ribosomal subunits. The gel was briefly washed in DEPC-treated water and then soaked in 20 × SSC buffer (3 M NaCl, 300 mM Na-citrate, pH 7.0) for 30 min. The RNA was transferred to positively charged nylon membranes (Boehringer Mannheim) for 1.5 h using the Posiblot apparatus (Stratagene). The membranes were washed for 5 min in 6 × SSC at 25 °C, and the RNA was cross-linked to the membrane using a UV cross-linker. The membranes were washed briefly in 6 × SSC at 25 °C and incubated for 5 h at 42 °C in prehybridization buffer (25 mM KH2PO4, pH 7.4, 5% Denhardt's solution, 50% formamide, 5 × SSC, and 50 µg/ml of salmon sperm DNA). Blots were incubated for at least 5 h at 42 °C with the appropriate probes in hybridization buffer (prehybridization buffer containing 100 mg/ml dextran sulfate). The probe for the alpha 2 subunit was a purified 314-bp PCR cDNA product that was amplified with specific primers (forward primer, 5'-GTT-AAA-GGA-GGT-CTG-TGC-AG-3'; reverse primer, 5'-TAA-CCT-ACG-CCA-ACA-AGT-CT-3') that had been internally labeled using Taq DNA polymerase and [alpha -32P]ATP (Dupont). After hybridization, the blots were subjected to various stringency washes, dried, and exposed to x-ray films, and the autoradiograms were scanned as described above for the PCR method. The integrated values for MAT II alpha 2 subunit bands were normalized to the corresponding GAPDH bands to allow comparisons of samples. The size of the hybridized bands was determined by comparing the relative migration to that of the 28 and 18 S ribosomal subunits.

Measurement of AdoMet Levels

PBMC were cultured with medium alone or stimulated with either PHA or SEB as described above and then harvested at the desired time and counted. The cells were resuspended in 500 µl of ice-cold PBS and centrifuged in microcentrifuge tubes at 1800 × g, washed with ice-cold PBS, and frozen in liquid nitrogen. Cell extracts were prepared for analysis of AdoMet by lysing cells and precipitating proteins with 2 N perchloric acid (25). The acid-soluble extract was neutralized with 2 N KOH and 1 N KHCO3, chilled on ice for 10 min, and centrifuged to remove KClO4. The acid-insoluble precipitate was extracted again with 2 N PCA and used for the determination of DNA by the method of Burton (37). The neutralized acid-soluble extract was used for the determination of intracellular AdoMet levels by HPLC as detailed elsewhere (25) using a Waters Model 840 HPLC system with model 510 solvent delivery system, model 490 dual variable UV detector, and Model 710B intelligent sample process (WISP) with refrigeration.

Neutralized, cleared PCA extracts were injected onto a Whatman Partisil-10 SCX cation exchange column (0.46 × 25 cm) and eluted isocratically at 1 ml/min with 0.2 M ammonium formate, pH 4.0, and 10% acetonitrile (25). The absorbance was monitored at 260 and 280 nm, and the peaks were identified and integrated using an on-line digital computer and Waters HPLC software. Biologically active (-)AdoMet, used as the HPLC standard, was prepared using E. coli MAT (10 µg/ml) incubated with 1 mM L-Met in 100 mM Tris, pH 8.3, 100 mM KCl, 20 mM MgCl2, 2.5 mM ATP, 2 mM DTT, and 150 µg/ml of bovine serum albumin, for 1 h at 37 °C and was purified chromatographically on an HPLC C18 column (Waters microBondapak) as described previously (15).

Statistical Analyses

Experiments were conducted a minimum of three times, and statistical differences were evaluated by Student's t tests.


RESULTS

Effect of Mitogen and Superantigen Activation of T Cells on MAT Activity

Polyclonal mitogens and superantigens activate T cells by distinct mechanisms. Both types of T cell activators stimulate large numbers of T cells to proliferate; however, PHA usually stimulates at least twice as many cells as SEB (34). The difference in the mode of interaction of mitogen and superantigens with T cells can be reflected in the biochemical pathways used to program the cells to divide and/or differentiate (32). To investigate whether mitogen and superantigen may have different effects on the induction of MAT activity, PBMC were stimulated with optimal concentrations of either PHA or SEB, and we then measured the proliferative response and MAT activity. As expected, the proliferative response to PHA was significantly higher than that to SEB (Fig. 1). However, despite this difference in proliferative responses, there was no significant difference in MAT activity in PBMC cultures stimulated with either SEB or PHA (p > 0.8, Fig. 2); both stimuli induced a similar and significant increase in MAT activity compared with unstimulated cells. After 48 h in culture with PHA or SEB, MAT activity in PBMC increased by 2.4- and 3.2-fold, respectively, compared with unstimulated PBMC (p < 0.05).


Fig. 1. Difference in the magnitude of the proliferative response elicited by PHA and SEB. PBMC from three different individuals were each incubated at 2 × 105 cells/200 µl with either RPMI complete medium alone, PHA (2.5 µg/ml), or SEB (1 µg/ml). These concentrations of PHA and SEB were determined to be optimal in separate experiments. The proliferative response was evaluated at 24, 48, or 72 h by measuring the uptake of [3H]thymidine as described under "Experimental Procedures." The data shown are cpm ± S.D. from one representative responder, and the inset table shows the relative amount of DNA/106 cells in PHA- versus SEB-stimulated cells of three individuals. DNA was measured by the method of Burton (37).
[View Larger Version of this Image (26K GIF file)]


Fig. 2. Induction of MAT activity in mitogen- and superantigen-stimulated PBMC. PBMC (2 × 106/ml) were cultured with RPMI complete medium alone, with PHA (5 µg/ml), or with SEB (1 µg/ml) for the indicated time intervals. MAT specific activity was determined in cell extracts as described under "Experimental Procedures." MAT activity is expressed as units/mg of protein, where a unit of activity is defined as the amount of enzyme that catalyzes the formation of 1 nmol of AdoMet in 1 h. A, data from one individual; B, mean of three different individuals tested on different days. The asterisk indicates significant difference (p < 0.05) in cells stimulated with SEB or PHA compared with cells cultured in medium alone.
[View Larger Version of this Image (16K GIF file)]

Effect of Mitogen and Superantigen Activation of T Cells on MAT mRNA Expression

Inasmuch as PHA stimulates 80-90% of resting T cells, and whereas SEB is only capable of stimulating T cells that bear the appropriate Vbeta elements (usually 20-40% of resting T cells) (34), the finding that MAT activity was similar in both cultures suggests that, on a per cell basis, SEB may be inducing higher levels of MAT activity than that induced by PHA. Superantigen-stimulated cells may have higher MAT activity than PHA-stimulated cells due to a higher induction of MAT subunit expression or differences in MAT regulation elicited by SEB stimulation. To distinguish between these possibilities, the expression of MAT mRNA and protein was examined in PHA- and SEB-stimulated cells. PBMC were incubated with specific stimulators for 0, 8, 12, 24, 36, 48, and 72 h. At each time point, replicate cultures were harvested, and MAT alpha 2 subunit mRNA expression was determined by RT-PCR and Northern blots. As shown in Fig. 3, the kinetics of alpha 2 subunit mRNA induction by PHA and SEB was similar, peaking at 4-8 h after addition of the stimulus and declining to near base-line levels by 12 h (Fig. 3). Both PHA and SEB induced a 5-8-fold increase in the amount of alpha 2 subunit mRNA compared with unstimulated cells (Fig. 3).


Fig. 3. Expression of MAT II alpha 2 subunit mRNA in mitogen- and superantigen-stimulated PBMC. PBMC were cultured with medium alone or stimulated with PHA or SEB as described in Fig. 2. At the indicated times, the cells were harvested, total RNA was extracted, and the expression of MAT II alpha 2 subunit mRNA was analyzed by RT-PCR (A) or by Northern blots (B). A, RT-PCR analysis. RNA was reverse transcribed into cDNA that was amplified using specific primers that generated an alpha 2 subunit 870-bp product as detailed under "Experimental Procedures." The autoradiograms were scanned, and the normalized PCR values (scanned PCR value for the 870-bp alpha 2 subunit band divided by the scanned PCR value for 590-bp GAPDH internal control band for each lane) were graphed as a function of time. B, Northern blot analysis of the same RNA preparation was performed using a labeled 314-bp probe for the alpha 2 subunit and a 590-bp probe for GAPDH. The autoradiograms were scanned, and the normalized scanning values were graphed as a function of time. The normalized data are shown to the right of the panel. The data in a and b are from one of three representative experiments. C, mean ± S.E. of RT-PCR results from three experiments. The data were calculated relative to the base-line mRNA level of the alpha 2 subunit in each individual tested.
[View Larger Version of this Image (44K GIF file)]

Effect of Mitogen and Superantigen Activation of T Cells on the Expression of MAT Subunit Proteins

PBMC were incubated with PHA or SEB for 0, 8, 12, 24, 36, 48, and 72 h. At each time point, cell extracts were analyzed by immunoblots to determine the expression of MAT subunit proteins. As shown in Fig. 4, stimulation with either mitogen or superantigen caused a time-dependent decrease in lambda  protein, which nearly disappeared by 48 h after stimulation, while the amount of both alpha 2 and alpha 2' subunits increased concomitantly, relative to unstimulated cells cultured in medium alone. The relative increase in the alpha 2' compared with the alpha 2 subunit correlated with a higher MAT activity in SEB-stimulated cultures. However, the most striking difference between extracts of PHA- and SEB-stimulated cells was the finding that stimulation with superantigen induced a dramatic down-regulation of the beta subunit expression, which was no longer detectable by 72 h (Fig. 4A). These findings were reproducible when PBMC from different individuals were stimulated with this superantigen (Fig. 4B).


Fig. 4. Differential expression of MAT II alpha 2 subunit proteins in mitogen- and superantigen-stimulated PBMC. A, immunoblot of T cell extracts prepared at different time points after incubation with: M, medium alone; P, PHA (5 µg/ml); or S, SEB (1 µg/ml). Cells were extracted in hypotonic buffer containing protease inhibitors, and 125 µg of protein was loaded per lane and analyzed by SDS-PAGE (10% total acrylamide, 2.7% bisacrylamide). The separated proteins were electroblotted onto nitrocellulose membrane that was probed with polyclonal anti-alpha 2/alpha 2' beta  holoenzyme antibodies (22). The blots were developed with secondary anti-rabbit antibodies conjugated to horseradish peroxidase and the luminol-chemiluminescence reagents (Amersham ECL) as described under "Experimental Procedures." The processed blots were exposed to x-ray film, and the autoradiograms were analyzed and scanned. The blot shown is from one representative experiment. B, mean ± S.E. relative expression of MAT subunit proteins in cells cultured with medium alone, PHA, or SEB and extracted at different time intervals. The mean values were obtained by scanning three blots generated with cell extracts from different individuals. The data are expressed in arbitrary scanning units.
[View Larger Version of this Image (21K GIF file)]

Kinetic Properties of MAT from Mitogen- and Superantigen-activated Cells

We reported recently that PHA activated PBMC that expressed high levels of alpha 2/alpha 2', and beta  subunits appeared to have two kinetically different forms of MAT with a Km for L-Met of 16 and 80 µM (21). In addition, we reported that recombinant alpha 2/alpha 2' expressed in E. coli without the beta  subunit has a Km for L-Met of 80 µM (23). It was of interest, therefore, to determine the consequence of SEB-induced down-regulation of the beta  subunit on MAT kinetic properties. The Km for L-Met of MAT in extracts from 72-h cultures stimulated with either PHA or SEB was compared by the Lineweaver-Burk and the S/v versus S plots, which are commonly used to determine the presence of multiple enzymes catalyzing the same reaction (46). As shown in Fig. 5, MAT in the 72-h PHA-stimulated cell extracts, which consisted of alpha 2/alpha 2' and beta  subunits (Fig. 4), appeared to exist in two kinetic forms. These observations were also confirmed by computer curve fitting by nonlinear least squares. For, example, when MAT data from PHA-stimulated cell extracts, which has the alpha 2/alpha 2' and beta subunits, were fit to both single- and two-site Adair-Scatchard equations, the data clearly fit the two-site model better as indicated by improvement in correlation coefficient, coefficient of determination and chi 2. By analyzing the values for low (2.5-20 µM) and high (20-80 µM) L-Met concentrations separately, the data were consistent with the co-existence of two enzyme species with calculated Km values for L-Met of 53-74 µM (Vmax 9.7-12, correlation coefficient = 0.998, sum of squares = 0.071) and 23 µM (Vmax 5.3, correlation coefficient = 0.999, sum of squares = 0.013), respectively. Conversely, the kinetic data of MAT from SEB-stimulated cell extracts that lacked the beta  subunit clearly fit the single-site model based on the same criteria, with a Km value of 55-67 µM and a Vmax of 12-13.5, respectively (correlation coefficient = 0.997). Thus, in the absence of the beta  subunit, the Km for L-Met is higher, suggesting that beta  may be a regulatory subunit of MAT.


Fig. 5. Kinetic analysis of MAT in PHA- and SEB-activated PBMC. Extracts from PBMC stimulated with either PHA (5 µg/ml) or SEB (1 µg/ml) for 72 h were first checked by immunoblots as described in the legend for Fig. 4 to ensure the absence of the beta  subunit in SEB-stimulated cells and then used to determine the Km L-Met under the conditions described under "Experimental Procedures." A, Lineweaver-Burk plot (1/v = Km/Vmax × 1/[S] + 1/Vmax) of MAT in PHA-activated cells (alpha 2/alpha 2' and beta  subunits are expressed). Computer-assisted analysis revealed that the data are consistent with a two-catalytic species, with Km values for L-Met of 53-74 µM and 23 µM, respectively. B, Lineweaver-Burk plot of MAT in SEB-activated cells (alpha 2/alpha 2' but no beta  subunits). Computer-assisted analysis revealed that the data are consistent with a single-catalytic species, with a Km for L-Met of 55-67 µM. C, the S/v versus S plot (S/v = 1/Vmax × [S] + Ks/Vmax) of the MAT activity in the PHA extract analyzed in panel A.
[View Larger Version of this Image (17K GIF file)]

Effect of Mitogen and Superantigen Activation of T Cells on Intracellular AdoMet Levels

Intracellular AdoMet levels were determined by HPLC at different times following stimulation of PBMC with either mitogen or superantigen. Levels of AdoMet were higher in PHA- and SEB-stimulated cells compared with unstimulated cells (Fig. 6); however, the levels of AdoMet were markedly higher in SEB-stimulated compared with PHA-stimulated cells (Fig. 6). At 72 h, steady-state levels of AdoMet were 10-fold higher in SEB-stimulated cells compared with control cells (p < 0.01) and 4-6-fold higher than in PHA-stimulated cells (p < 0.02). The difference between AdoMet levels in cells stimulated with SEB or PHA was highest and more significant at the time point of total disappearance of the MAT II beta  subunit in SEB-stimulated cells. Based on an estimated volume of 0.69 µl/106 stimulated PBMC (26, 25), these data indicate that AdoMet concentrations can exceed 100 µM in cells stimulated via a physiological route.


Fig. 6. Determination of AdoMet Levels in PHA- and SEB-stimulated PBMC. PBMC were cultured at 2 × 106 cells/ml with either RPMI complete medium alone, PHA (5 µg/ml), or SEB (1 µg/ml). At the indicated time intervals, the cells (2-4 × 107) were harvested, counted, and extracted with 2 N perchloric acid. AdoMet levels were determined in the neutralized acid-soluble PCA extracts as detailed under "Experimental Procedures." The amount of AdoMet (pmol) was determined from a standard curve that was generated using biologically synthesized and purified (-)AdoMet. The data are expressed as pmol/106 cells or pmol/ng DNA as indicated on the Y axes. Significant differences were determined by Student's t test.
[View Larger Version of this Image (25K GIF file)]

Effect of AdoMet on MAT Activity in Extracts of Mitogen- and Superantigen-activated Cells

According to the kinetic analysis of alpha 2/alpha 2' beta  MAT II from human T cells, AdoMet is a potent inhibitor of its own synthesis, particularly in the presence of Pi and PPi (24). The finding that both MAT activity and AdoMet levels were higher in superantigen-activated compared with mitogen-activated cells suggested that the enzyme may be differentially regulated in cells stimulated by these distinct stimuli. Guided by the knowledge that AdoMet activates hepatic MAT III (alpha 1)2 and moderately inhibits MAT I (alpha 1)4 (6), we hypothesized that in the absence of beta , the alpha 2/alpha 2' polymeric forms of MAT II may be less susceptible to feedback inhibition by AdoMet. We, therefore, investigated whether the SEB-induced down-regulation of the beta  subunit has an effect on the feedback inhibition of MAT by AdoMet. As shown in Table I, MAT from 72-h activated SEB extracts (alpha 2/alpha 2' but no beta  subunits) was almost 2-fold less inhibited by AdoMet compared with MAT from PHA-stimulated cells (alpha 2/alpha 2' and beta  subunits).

Table I. AdoMet-mediated feedback inhibition of MAT activity in PHA- and SEB-stimulated cells

Extracts from PBMC that were activated for 72 h with PHA (alpha 2/alpha 2' and beta  subunits are expressed) or SEB (only alpha 2/alpha 2' subunits are expressed) were assayed for MAT activity in the absence or presence of 25 µM AdoMet.

Cell culture MAT activity
% Inhibition
Without AdoMet With AdoMet (25 µM)

units/ml
PHA (5 µg/ml) 31.1 17.2 45
SEB (1 µg/ml) 40.4 30.0 26


DISCUSSION

Activation of resting T cells triggers biochemical signals that initiate a cascade of events leading to cellular differentiation and proliferation. AdoMet plays a key role in these events, and as the major methyl group donor, it regulates protein activity, RNA stability, and gene expression in addition to acting as a cofactor for several enzymatic reactions and as a precursor for the polyamines (39-41). It is reasonable, therefore, to assume that the levels of AdoMet need to be tightly regulated to meet specific cellular demands at the different stages of T cell activation and differentiation.

The regulation of cellular AdoMet concentrations can be achieved at the level of its synthesis by MAT and/or its utilization via transmethylation and polyamine synthesis pathways. Our studies have focused on the regulation of MAT activity in human lymphocytes as a means for regulating AdoMet levels. In previous studies, we reported that activation of T cells is accompanied by an increase in MAT activity that was associated with a decline in the lambda  subunit and a concomitant increase in the alpha 2 and alpha 2' catalytic subunits (21). In this study, the use of a superantigen as a T cell stimulator revealed that stimulation of T cells via the physiological route induces specific changes in MAT subunit expression and kinetic and regulatory properties that were not observed in nonphysiologically stimulated, mitogen-activated T cells.

Superantigens are potent T cell stimulators that stimulate T cells in a manner similar to that of conventional antigen because they interact with the T cell via the alpha beta TCR (for review, see Refs. 34 and 35). However, superantigens interact with specific Vbeta elements found on the outside of the variable region of the TCR beta  chain (Vbeta elements) and, thus, are less specific than antigen. Each superantigen has a characteristic affinity for 1-5 of the 25 human TCR Vbeta elements and can stimulate all T cells expressing them. Consequently, a given superantigen can stimulate from 5 to 40% of resting T cells compared with <= 0.001% stimulated by an antigen (34). The ability of superantigen to stimulate large numbers of T cells, plus the fact that stimulation is via the TCR, provides an ideal system for studying biochemical events triggered in T cells under conditions that mimic antigenic stimulation (32).

In previous studies, we have shown that the signaling and molecular requirements for T cell stimulation by nonspecific mitogens are different from those for superantigen (31-33). Here we showed that like PHA, superantigen induces down-regulation of lambda  and up-regulation of alpha  and alpha ' expression; however, unlike PHA, superantigen seems to down-regulate the expression of the beta  subunit. We have reported that lambda  and alpha 2/alpha 2' are capable of catalyzing the synthesis of AdoMet; whereas, beta  subunit has no known catalytic function (21). The data from this study suggest that the beta  subunit may exert a regulatory effect on the enzyme activity.

Regulation of MAT activity by differential subunit oligomerization has been reported for the hepatic isozymes MAT I/III (4, 6). The tetrameric form, MAT I (alpha 1)4 has a Km for L-Met of 3-14 µM, whereas, the alpha 1 dimer, MAT III, has a Km of 200 µM (4, 6, 13). The physiologic relevance for the existence of different oligomeric states of the hepatic form of MAT is not entirely clear; however, these isozymes are starkly different in their kinetic and physical properties as well as in their regulation by AdoMet (4, 6). At physiological concentrations of L-Met, MAT I was reported to be 10-fold more active than MAT III (7). In addition, MAT I is feedback-inhibited by AdoMet, whereas, MAT III shows positive cooperativity and is markedly activated by concentrations of AdoMet between 50-500 µM (6). Whether a balance between MAT I and MAT III is important for normal liver function and metabolism is not entirely clear; however, studies by Mato and coworkers (4, 42-44) revealed that the ratio of MAT I to MAT III can be regulated, in part, by oxido/reduction of the enzyme sulfhydryl group and that the ratio of reduced form (GSH) of glutathione/oxidized form (GSSG) of glutathione can affect the enzyme oligomeric state.

The data presented here, together with several previous observations (21, 23), suggest that MAT II may also be regulated by differential oligomerization of its subunit proteins alpha 2, alpha 2', and beta . In our earlier studies, we reported that MAT II purified from leukemic cells, which consist of the alpha 2, alpha 2', and beta  subunits, had a Km for L-Met of 3.8 µM (24). Detailed kinetic analysis of this pure enzyme allowed us to develop a steady-state kinetic model that correctly predicted the in situ MAT activity in human leukemia cells expressing the alpha 2/alpha 2' and beta  subunits (25). However, when the model was applied to resting, freshly isolated T cells from healthy individuals, the predicted value for MAT activity was higher than the measured value (25). This difference was explained by the finding that in resting T cells MAT exists as a less active 68-kDa lambda  form (21, 25). Activation of T cells resulted in the replacement of lambda  with the alpha 2/alpha 2' subunits (21). The increase in the alpha 2/alpha 2' subunits was accompanied by an increase in MAT activity, suggesting that the alpha 2/alpha 2' subunits are more catalytically active than the lambda  subunit. Attempts to separate the beta  subunit from the holoenzyme revealed that this subunit has no MAT catalytic activity (21, 23). The possibility that the beta  subunit may have a regulatory role in MAT II activity was first suggested from experiments showing that purified recombinant alpha 2/alpha 2' subunits expressed in E. coli had a Km for L-Met of 80 µM, which was considerably higher than that of the pure alpha 2/alpha 2'beta holoenzyme form (23).

The data presented in this study support the role of the beta  subunit in regulating MAT activity. In SEB-stimulated cells, beta was no longer detected after 72 h of culture, and kinetic analysis revealed that MAT in extracts of these cells has a Km for L-Met of 55-67 µM and a Vmax of 12-13.5. By contrast, PHA-stimulated cells, which expressed the alpha 2, alpha 2', and beta  subunits, appeared to have two kinetic forms of MAT with Km for L-Met of 53-74 µM (Vmax 9.7-12) and 23 µM (Vmax 5.3), respectively. We propose that at 72 h, the relative amount of alpha 2/alpha 2' subunits is higher than the beta  subunit in PHA-stimulated cells, allowing both homomeric and heteromeric association of MAT subunits, where the alpha 2/alpha 2' homomer has a Km of 53-74 µM and the alpha 2/alpha 2'beta heteromer has a Km of 23 µM. Clearly, these possibilities need to be investigated directly with more detailed structural analyses. Nonetheless, the data presented here suggest that the beta  subunit lowers the Km of the enzyme for L-Met while rendering it more susceptible to feedback inhibition by AdoMet. The negative regulatory role of beta  may explain the finding that AdoMet levels were 3-5-fold higher in SEB compared with PHA-stimulated cells. Down-regulation of the beta  subunit may be required in physiologically stimulated cells to relieve MAT from being feedback inhibited by its product, thereby allowing a concomitant increase in both synthesis and steady-state levels of this important molecule. Indeed, AdoMet levels reached 100 µM in SEB-stimulated cells. It is tempting to speculate that this mode of regulation of MAT via differential subunit association may be necessary to achieve appropriate levels of AdoMet that are required for physiological activation and functional differentiation of T cells at specific stages of the cell cycle.


FOOTNOTES

*   This work was supported by National Institutes of Health Grant GM-54892-06.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
**   To whom all correspondence should be addressed: VAMC (151), 1030 Jefferson Ave., Memphis, TN 38104. Tel.: 901-448-7247; Fax: 901-448-7208.
1   The abbreviations used are: MAT, methionine adenosyltransferase; AdoMet, S-adenosylmethionine; PBMC, peripheral blood mononuclear cells; SEB, staphylococcal enterotoxin B; PHA, phytohemagglutinin; TCR, T cell receptor for antigen; PAGE, polyacrylamide gel electrophoresis; PCA, perchloric acid; DTT, dithiothreitol; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; TES, 2-{[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]amino}ethanesulfonic acid; TBS, Tris-buffered saline; RT-PCR, reverse transcriptase-polymerase chain reaction; bp, base pair(s); MOPS, 4-morpholinepropanesulfonic acid; HPLC, high pressure liquid chromatography.

ACKNOWLEDGEMENTS

The authors are grateful to Dr. Harry Jarrett for helpful discussion regarding computer-assisted analysis of kinetic data and to Mr. Hesham Basma for help with photographic scanning.


REFERENCES

  1. Mudd, S. H. (1973) in The Enzymes Group Transfer Part A (Bayer, P. D., ed), Third Ed., Vol. III, pp. pp.121-154
  2. Tabor, C. W., and Tabor, H. (1984) Adv. Enzymol. Relat. Areas Mol. Biol. 56, 251-282 [Medline] [Order article via Infotrieve]
  3. Kotb, M., and Geller, A. M. (1993) Pharmacol. & Ther. 59, 125-143 [Medline] [Order article via Infotrieve]
  4. Pajares, M. A., Corrales, F., Duran, C., Mato, J. M., and Alvarez, L. (1992) FEBS Lett. 309, 1-4 [CrossRef][Medline] [Order article via Infotrieve]
  5. Hoffman, J. L. (1983) Methods Enzymol. 94, 223-228 [Medline] [Order article via Infotrieve]
  6. Sullivan, D. M., and Hoffman, J. L. (1983) Biochemistry 22, 1636-1641 [Medline] [Order article via Infotrieve]
  7. Cabrero, C., Puerta, J., and Alemany, S. (1987) Eur. J. Biochem. 170, 299-304 [Abstract]
  8. Kotb, M., Mudd, H. S., Mato, J. M., Geller, A. M., Kredich, N. M., Chou, J., and Cantoni, J. (1996) Trends Genet. 13, 51-52 [CrossRef]
  9. Tsukada, K., and Okada, G. (1980) Biochem. Biophys. Res. Commun. 94, 1078-1082 [Medline] [Order article via Infotrieve]
  10. Okada, G., Teaoka, H., and Tsukada, K. (1981) Biochemistry 20, 934-940 [Medline] [Order article via Infotrieve]
  11. Cabrero, C., and Alemany, S. (1988) Biochim. Biophys. Acta 952, 277-281 [Medline] [Order article via Infotrieve]
  12. Alvarez, L., Mingorance, J., Pajares, M. A., and Mato, J. M. (1994) Biochem. J. 261, 557-561
  13. Suma, Y., Shimizu, K., and Tsukada, K. (1986) J. Biochem. (Tokyo) 100, 67-75 [Abstract]
  14. Oden, K., and Clarke, S. (1983) Biochemistry 22, 2978-2986 [Medline] [Order article via Infotrieve]
  15. Kotb, M., and Kredich, N. M. (1985) J. Biol. Chem. 260, 3923-3930 [Abstract]
  16. Mitsui, K., Teraoka, H., and Tsukada, K. (1988) J. Biol. Chem. 263, 11211-11216 [Abstract/Free Full Text]
  17. Horikawa, S., Sasuga, J., Shimizu, K., Ozasa, H., and Tsukada, K. (1990) J. Biol. Chem. 265, 13683-13686 [Abstract/Free Full Text]
  18. Geller, A. M., Kotb, M. Y., Jernigan, H. M., Jr., and Kredich, N. M. (1986) Exp. Eye Res. 43, 997-1008 [Medline] [Order article via Infotrieve]
  19. Liau, M. C., Chang, C. F., Belanger, L., and Grenier, A. (1979) Cancer Res. 39, 162-169 [Medline] [Order article via Infotrieve]
  20. Horikawa, S., and Tsukada, K. (1992) FEBS Lett. 312, 37-41 [CrossRef][Medline] [Order article via Infotrieve]
  21. De La Rosa, J., Le Gros, H. L., Jr., Geller, A. M., and Kotb, M. (1992) J. Biol. Chem. 267, 10699-10704 [Abstract/Free Full Text]
  22. Kotb, M., Geller, A. M., Markham, G. D., Kredich, N. M., De La Rosa, J., and Beachey, E. H. (1990) Biochim. Biophys. Acta 1040, 137-144 [Medline] [Order article via Infotrieve]
  23. De La Rosa, J., Ostrowski, J., Hryniewicz, M. M., Kredich, N. M., Kotb, M., LeGros, H. L., Jr., Valentine, M., and Geller, A. M. (1995) J. Biol. Chem. 270, 21860-21868 [Abstract/Free Full Text]
  24. Kotb, M., and Kredich, N. M. (1990) Biochim. Biophys. Acta 1039, 253-260 [Medline] [Order article via Infotrieve]
  25. De La Rosa, J., Geller, A. M., LeGros, H. L., Jr., and Kotb, M. (1992) Cancer Res. 52, 3361-3366 [Abstract]
  26. German, D. C., Bloch, C. A., and Kredich, N. M. (1983) J. Biol. Chem. 258, 10997-11003 [Abstract/Free Full Text]
  27. Janeway, C. A., Jr. (1992) Annu. Rev. Immunol. 10, 645-674 [CrossRef][Medline] [Order article via Infotrieve]
  28. Cantrell, D. (1996) Annu. Rev. Immunol. 14, 259-274 [CrossRef][Medline] [Order article via Infotrieve]
  29. Linsley, P. S., and Ledbetter, J. A. (1993) Annu. Rev. Immunol. 11, 191-212 [CrossRef][Medline] [Order article via Infotrieve]
  30. Frank, S. J., Niklinska, B. B., Orloff, D. G., Mercep, M., Ashwell, J. D., and Klausner, R. D. (1990) Science 249, 174-177 [Medline] [Order article via Infotrieve]
  31. Majumdar, G., Beachey, E. H., Tomai, M., and Kotb, M. (1991) Cell. Signalling 2, 521-530
  32. Ohnishi, H., Ledbetter, J. A., Kanner, S. B., Linsley, P. S., Tanaka, T., Geller, A. M., and Kotb, M. (1995) J. Immunol. 154, 3180-3193 [Abstract/Free Full Text]
  33. Kotb, M., Dale, J. B., and Beachey, E. H. (1987) J. Immunol. 139, 202-206 [Abstract/Free Full Text]
  34. Marrack, P., and Kappler, J. (1990) Science 248, 705-711 [Medline] [Order article via Infotrieve]
  35. Kotb, M. (1995) Clin. Microbiol. Rev. 8, 411-426 [Abstract]
  36. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  37. Butron, K. (1956) Biochem. J. 62, 315-319
  38. Kotb, M., Watanabe-Ohnishi, R., Wang, B., Tomai, M. A., LeGros, H. L., Jr., Schlievert, P., El Demellawy, M., and Geller, A. (1993) Immunomethods 2, 33-40 [CrossRef]
  39. Bird, A. (1992) Cell 70, 5-8 [Medline] [Order article via Infotrieve]
  40. Clarke, S. (1993) Curr. Opin. Cell Biol. 5, 977-983 [Medline] [Order article via Infotrieve]
  41. Carbone, A. M., Marrack, P., and Kappler, J. W. (1988) Science 242, 1174-1176 [Medline] [Order article via Infotrieve]
  42. Corrales, F., Cabrero, C., Pajares, M. A., Ortiz, P., Martin, D. A., and Mato, J. M. (1990) Hepatology 11, 216-222 [Medline] [Order article via Infotrieve]
  43. Corrales, F., Ochoa, P., Rivas, C., Martin, L. M., Mato, J. M., and Pajares, M. A. (1991) Hepatology 14, 528-533 [Medline] [Order article via Infotrieve]
  44. Mato, J. M., Alvarez, L., Ortiz, P., Mingorance, J., Duran, C., and Pajares, M. A. (1994) Adv. Exp. Med. Biol. 368, 113-1177 [Medline] [Order article via Infotrieve]
  45. Klotz, I. M. (1946) Arch. Biochem. 8, 109-117
  46. Segel, I. W. (1975) Enzyme Kinetics, pp. 64-71, Wiley-Interscience, New York

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.